PEG-MGF

PEG-MGF (PEGylated Mechano Growth Factor) is a synthetic peptide analog of a splice variant of insulin-like growth factor-1 (IGF-1) referred to in the literature as MGF, modified through the attachment of a polyethylene glycol (PEG) moiety. The PEGylation is intended to extend the molecule's circulating half-life relative to native MGF, which is described in research as being rapidly cleared. This product is supplied in lyophilized form for laboratory research and professional reference use only. It is a research compound and is not approved by the FDA for therapeutic use.

Within the Growth Hormone and Performance category, PEG-MGF is of interest in preclinical and academic literature exploring local tissue signaling, satellite cell activity, and the IGF-1 family of growth factors. All characterizations here are framed for licensed-practitioner reference and are not intended as patient-directed marketing or as any representation of clinical benefit.

• Investigated in preclinical literature for its reported relationship to skeletal muscle satellite cell activation and proliferation following mechanical loading or tissue stress (individual results vary)
• Studied in research models in connection with local muscle tissue signaling associated with the MGF splice variant of IGF-1 (individual results vary)
• Examined in academic settings for its relationship to the broader IGF-1 growth factor pathway and downstream cellular responses described in the literature (individual results vary)
• Reported in research contexts as a PEGylated analog studied for extended peptide stability and prolonged signaling duration relative to native MGF (individual results vary)
• Of interest in performance and recovery research literature exploring growth-factor-mediated cellular mechanisms (individual results vary)

Reference handling for research use: supplied as a lyophilized powder. A common laboratory approach is to reconstitute with bacteriostatic water, or with sterile water where appropriate, introducing the diluent gradually and allowing the powder to go into solution without vigorous agitation. Lyophilized material is generally held refrigerated for near-term use, with frozen conditions used for longer-term storage; once reconstituted, solutions are typically maintained under refrigeration. Protect the vial from light, heat, and repeated freeze-thaw cycles, and keep it sealed until use. The information above is general storage and handling reference only; all clinical protocols, including any reconstitution, dosing, and administration decisions, are determined solely by the licensed ordering provider at their professional discretion. This is reference information for licensed professionals and is not medical advice.

A per-lot Certificate of Analysis, HPLC purity profile, and mass-spectrometry verification are available on request for this product. Ask your account manager for the current lot documentation.

PEG-MGF is the PEGylated form of mechano growth factor, a splice variant of IGF-1 that the literature describes as being expressed locally in response to mechanical stress or tissue damage. The proposed mechanism studied in preclinical research centers on the reported activation and proliferation of muscle satellite (stem) cells, which the literature associates with local muscle tissue signaling. The PEG (polyethylene glycol) modification is intended to slow enzymatic degradation and renal clearance, thereby extending the molecule's circulating presence relative to unmodified MGF. These mechanistic descriptions reflect proposed and studied pathways in the research literature only; individual results vary and no clinical outcome is implied.